283 related articles for article (PubMed ID: 35163121)
1. Alpha-Lipoic Acid Inhibits Spontaneous Diabetes and Autoimmune Recurrence in Non-Obese Diabetic Mice by Enhancing Differentiation of Regulatory T Cells and Showed Potential for Use in Cell Therapies for the Treatment of Type 1 Diabetes.
Huang SH; Kuo SL; Chen SJ; Lin JR; Chen YW; Hong ZJ; Sytwu HK; Lin GJ
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163121
[TBL] [Abstract][Full Text] [Related]
2. Dimethyl sulfoxide inhibits spontaneous diabetes and autoimmune recurrence in non-obese diabetic mice by inducing differentiation of regulatory T cells.
Lin GJ; Sytwu HK; Yu JC; Chen YW; Kuo YL; Yu CC; Chang HM; Chan DC; Huang SH
Toxicol Appl Pharmacol; 2015 Jan; 282(2):207-14. PubMed ID: 25481496
[TBL] [Abstract][Full Text] [Related]
3. Endogenous expansion of regulatory T cells leads to long-term islet graft survival in diabetic NOD mice.
Shi Q; Lees JR; Scott DW; Farber DL; Bartlett ST
Am J Transplant; 2012 May; 12(5):1124-32. PubMed ID: 22299822
[TBL] [Abstract][Full Text] [Related]
4. KLRG1 expression identifies short-lived Foxp3
Kornete M; Mason E; Istomine R; Piccirillo CA
Autoimmunity; 2017 Sep; 50(6):354-362. PubMed ID: 28850267
[TBL] [Abstract][Full Text] [Related]
5. Activated protein C inhibits pancreatic islet inflammation, stimulates T regulatory cells, and prevents diabetes in non-obese diabetic (NOD) mice.
Xue M; Dervish S; Harrison LC; Fulcher G; Jackson CJ
J Biol Chem; 2012 May; 287(20):16356-64. PubMed ID: 22447930
[TBL] [Abstract][Full Text] [Related]
6. InsB9-23 Gene Transfer to Hepatocyte-Based Combined Therapy Abrogates Recurrence of Type 1 Diabetes After Islet Transplantation.
Russo F; Citro A; Squeri G; Sanvito F; Monti P; Gregori S; Roncarolo MG; Annoni A
Diabetes; 2021 Jan; 70(1):171-181. PubMed ID: 33122392
[TBL] [Abstract][Full Text] [Related]
7. Th1-Like ICOS+ Foxp3+ Treg Cells Preferentially Express CXCR3 and Home to β-Islets during Pre-Diabetes in BDC2.5 NOD Mice.
Kornete M; Mason ES; Girouard J; Lafferty EI; Qureshi S; Piccirillo CA
PLoS One; 2015; 10(5):e0126311. PubMed ID: 25946021
[TBL] [Abstract][Full Text] [Related]
8. Effects of streptozotocin on autoimmune diabetes in NOD mice.
Koulmanda M; Qipo A; Auchincloss H; Smith RN
Clin Exp Immunol; 2003 Nov; 134(2):210-6. PubMed ID: 14616779
[TBL] [Abstract][Full Text] [Related]
9. Induction of robust diabetes resistance and prevention of recurrent type 1 diabetes following islet transplantation by gene therapy.
Tian C; Ansari MJ; Paez-Cortez J; Bagley J; Godwin J; Donnarumma M; Sayegh MH; Iacomini J
J Immunol; 2007 Nov; 179(10):6762-9. PubMed ID: 17982066
[TBL] [Abstract][Full Text] [Related]
10. Effect of lipoic acid on cyclophosphamide-induced diabetes and insulitis in non-obese diabetic mice.
Faust A; Burkart V; Ulrich H; Weischer CH; Kolb H
Int J Immunopharmacol; 1994 Jan; 16(1):61-6. PubMed ID: 8150556
[TBL] [Abstract][Full Text] [Related]
11. Valproic Acid Suppresses Autoimmune Recurrence and Allograft Rejection in Islet Transplantation through Induction of the Differentiation of Regulatory T Cells and Can Be Used in Cell Therapy for Type 1 Diabetes.
Lin JR; Huang SH; Wu CH; Chen YW; Hong ZJ; Cheng CP; Sytwu HK; Lin GJ
Pharmaceuticals (Basel); 2021 May; 14(5):. PubMed ID: 34067829
[TBL] [Abstract][Full Text] [Related]
12. TNF-alpha down-regulates type 1 cytokines and prolongs survival of syngeneic islet grafts in nonobese diabetic mice.
Rabinovitch A; Suarez-Pinzon WL; Sorensen O; Rajotte RV; Power RF
J Immunol; 1997 Dec; 159(12):6298-303. PubMed ID: 9550435
[TBL] [Abstract][Full Text] [Related]
13. Anti-TCR mAb induces peripheral tolerance to alloantigens and delays islet allograft rejection in autoimmune diabetic NOD mice.
Deng R; Khattar M; Xie A; Schroder PM; He X; Chen W; Stepkowski SM
Transplantation; 2014 Jun; 97(12):1216-24. PubMed ID: 24854475
[TBL] [Abstract][Full Text] [Related]
14. CD4+CD25+ regulatory T cells control the progression from periinsulitis to destructive insulitis in murine autoimmune diabetes.
Ott PA; Anderson MR; Tary-Lehmann M; Lehmann PV
Cell Immunol; 2005 May; 235(1):1-11. PubMed ID: 16122720
[TBL] [Abstract][Full Text] [Related]
15. Adoptive cell therapy using antigen-specific CD4⁻CD8⁻T regulatory cells to prevent autoimmune diabetes and promote islet allograft survival in NOD mice.
Zhang D; Zhang W; Ng TW; Wang Y; Liu Q; Gorantla V; Lakkis F; Zheng XX
Diabetologia; 2011 Aug; 54(8):2082-92. PubMed ID: 21594554
[TBL] [Abstract][Full Text] [Related]
16. Regulatory T cells prevent transfer of type 1 diabetes in NOD mice only when their antigen is present in vivo.
Tonkin DR; He J; Barbour G; Haskins K
J Immunol; 2008 Oct; 181(7):4516-22. PubMed ID: 18802054
[TBL] [Abstract][Full Text] [Related]
17. Prevention of murine autoimmune diabetes by CCL22-mediated Treg recruitment to the pancreatic islets.
Montane J; Bischoff L; Soukhatcheva G; Dai DL; Hardenberg G; Levings MK; Orban PC; Kieffer TJ; Tan R; Verchere CB
J Clin Invest; 2011 Aug; 121(8):3024-8. PubMed ID: 21737880
[TBL] [Abstract][Full Text] [Related]
18. PLG scaffold delivered antigen-specific regulatory T cells induce systemic tolerance in autoimmune diabetes.
Graham JG; Zhang X; Goodman A; Pothoven K; Houlihan J; Wang S; Gower RM; Luo X; Shea LD
Tissue Eng Part A; 2013 Jun; 19(11-12):1465-75. PubMed ID: 23432371
[TBL] [Abstract][Full Text] [Related]
19. Artesunate prevents type 1 diabetes in NOD mice mainly by inducing protective IL-4-producing T cells and regulatory T cells.
Li Z; Shi X; Liu J; Shao F; Huang G; Zhou Z; Zheng P
FASEB J; 2019 Jul; 33(7):8241-8248. PubMed ID: 30916998
[TBL] [Abstract][Full Text] [Related]
20. Role of ICOS pathway in autoimmune and alloimmune responses in NOD mice.
Ansari MJ; Fiorina P; Dada S; Guleria I; Ueno T; Yuan X; Trikudanathan S; Smith RN; Freeman G; Sayegh MH
Clin Immunol; 2008 Feb; 126(2):140-7. PubMed ID: 17889619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
